- Home
- PLTR vs JNJ Comparison
PLTR vs JNJ Comparison
Compare PLTR & JNJ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PLTR | JNJ |
|---|---|---|
| Founded | 2003 | 1886 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Retail: Computer Software & Peripheral Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 433.2B | 449.6B |
| IPO Year | 2020 | 1944 |
Fundamental Metrics
Financial Performance| Metric | PLTR | JNJ |
|---|---|---|
| Price | $182.68 | $211.58 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 19 | 15 |
| Target Price | $171.74 | ★ $204.00 |
| AVG Volume (30 Days) | ★ 42.5M | 9.6M |
| Earning Date | 02-02-2026 | 01-21-2026 |
| Dividend Yield | N/A | ★ 2.46% |
| EPS Growth | ★ 116.04 | 71.26 |
| EPS | 0.43 | ★ 10.35 |
| Revenue | $3,896,163,000.00 | ★ $92,149,000,000.00 |
| Revenue This Year | $56.55 | $6.60 |
| Revenue Next Year | $42.67 | $5.28 |
| P/E Ratio | $399.43 | ★ $20.45 |
| Revenue Growth | ★ 47.23 | 5.08 |
| 52 Week Low | $63.40 | $140.68 |
| 52 Week High | $207.52 | $212.27 |
Technical Indicators
Market Signals| Indicator | PLTR | JNJ |
|---|---|---|
| Relative Strength Index (RSI) | 56.28 | 73.40 |
| Support Level | $168.83 | $199.91 |
| Resistance Level | $190.39 | $207.02 |
| Average True Range (ATR) | 5.92 | 3.16 |
| MACD | 2.35 | 0.12 |
| Stochastic Oscillator | 79.55 | 98.54 |
Price Performance
Historical ComparisonAbout PLTR Palantir Technologies Inc.
Palantir is an analytical software company that focuses on leveraging data to create efficiencies in its clients' organizations. The firm serves commercial and government clients via its Foundry and Gotham platforms, respectively. Palantir works only with entities in Western-allied nations and reserves the right not to work with anyone that is antithetical to Western values. The Denver-based company was founded in 2003 and went public in 2020.
About JNJ Johnson & Johnson
Johnson & Johnson is the world's largest and most diverse healthcare firm. It has two divisions: innovative medicine and medtech. These now represent all of the company's sales following the divestment of the consumer business, Kenvue, in 2023. After restructurings in 2023-24, the drug division focuses on three main therapeutic areas: immunology, oncology, and neurology. Geographically, just over half of total revenue is generated in the United States.